NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

CUSIP: 44975P103

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Total 13F shares
23,316,491
Total 13F value
$1,130,077,433
Holder snapshot 6 signals
Share change
+10,116,771
SEC-reported price per share
$48.47
Number of holders
78
Value change
+$490,958,954
Number of buys
54
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
265,214,861

Security key

44975P103

Report period

Q1 2021

Institutions

78

Top holders

10

NBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2021 Previous quarter: Q4 2020 NovaBridge Biosciences SEC filings NovaBridge Biosciences company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Cederberg Capital Ltd
Disclosed value leader
Cederberg Capital Ltd
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 0.67% Showing 1-6 of 15 holder rows.

Quick read

Cederberg Capital Ltd leads the comparable SEC ownership view at 0.67%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Cederberg Capital Ltd's linked filing trail.
Comparable ownership Top 5
Cederberg Capital Ltd 0.67%
Avidity Partners Management LP 0.6%
HHLR ADVISORS, LTD. 0.56%
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.53%
Artisan Partners Limited Partnership 0.32%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Cederberg Capital Ltd
13F
Company
13F
0.67%
$83,869,000
1,778,770 shares
 — 31 Dec 2020
Avidity Partners Management LP
13F
Company
13F
0.6%
$75,016,000
1,591,000 shares
 — 31 Dec 2020
HHLR ADVISORS, LTD.
13F
Company
13F
0.56%
$70,562,000
1,496,540 shares
 — 31 Dec 2020
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
0.53%
$66,213,000
1,404,300 shares
 — 31 Dec 2020
Artisan Partners Limited Partnership
13F
Company
13F
0.32%
$40,394,000
856,712 shares
 — 31 Dec 2020
WFM ASIA (BVI) Ltd
13F
Company
13F
0.28%
$35,501,000
752,937 shares
 — 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
78
Shares
23,316,491
Rows available
78
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
63
Q1 2021 holders
78
Holder diff
15
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .